aminocaproic acid has been researched along with Burns in 4 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid has also emerged as a promising agent in aesthetic surgery and burn care, due to its favorable safety profile and role in reducing blood loss, achieving an improved surgical field, and reducing edema and ecchymosis." | 2.58 | Antifibrinolytic Agents in Plastic Surgery: Current Practices and Future Directions. ( Brown, S; Taub, PJ; Yao, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, S | 1 |
| Yao, A | 1 |
| Taub, PJ | 1 |
| MONSAINGEON, A | 1 |
| TANRET, P | 1 |
| MADERA, R | 1 |
| MARSICO, V | 1 |
| Levitskiĭ, AP | 1 |
| Zheleznyĭ, VI | 1 |
| Litvinov, PG | 1 |
| Kadyshev, IuG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of TRanEXamic Acid in Reduction Mammoplasty (TREX-ARM): a Double-blinded Randomized Controlled Trial[NCT04947514] | Phase 4 | 98 participants (Actual) | Interventional | 2021-10-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The number of breasts with clinically significant hematoma (collection of blood under the skin) requiring either conservative management or operative washout was determined. (NCT04947514)
Timeframe: Up to 30 days
| Intervention | breasts (Number) |
|---|---|
| Treatment Side (Right or Left) | 2 |
| Placebo Side (Right or Left) | 1 |
The number of participants requiring blood transfusion was based on the postoperative decline in hematocrit level (NCT04947514)
Timeframe: Up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Side (Right or Left) | 0 |
| Placebo Side (Right or Left) | 0 |
Incidence of clinically significant deep vein thrombosis or pulmonary embolism detected on imaging (ultrasound or CT scan) (NCT04947514)
Timeframe: Up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Side (Right or Left) | 0 |
| Placebo Side (Right or Left) | 0 |
1 review available for aminocaproic acid and Burns
| Article | Year |
|---|---|
Antifibrinolytic Agents in Plastic Surgery: Current Practices and Future Directions.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Burns; Clinical Trials as Topic; Cohort Studies; Forecas | 2018 |
3 other studies available for aminocaproic acid and Burns
| Article | Year |
|---|---|
[TOWARD A TREATMENT OF TEGUMENTAL LESIONS OF THERMAL ORIGIN].
Topics: Aminocaproates; Aminocaproic Acid; Anti-Allergic Agents; Burns; Carbon Dioxide; Cortisone; Cytochrom | 1964 |
[EPSILON AMINOCAPROIC ACID AND EXPERIMENTAL BURNS. II ].
Topics: Aminocaproates; Aminocaproic Acid; Animals; Burns; Lagomorpha; Pharmacology; Rabbits; Research; Woun | 1964 |
[Use of epsilon-aminocaproic acid for treating granulating burn wounds].
Topics: Adolescent; Adult; Aged; Aminocaproates; Aminocaproic Acid; Bandages; Burns; Combined Modality Thera | 1986 |